Measurements that you are about to see were performed using the Klippel Near-field Scanner (NFS). This is a robotic measurement system that analyzes the speaker all around and is able (using advanced mathematics and dual scan) to subtract room reflections (so where I measure it doesn't matter). It also measures the speaker at close distance ("near-field") which sharply reduces the impact of room noise. Both of these factors enable testing in ordinary rooms yet results that can be more accurate than an anechoic chamber. In a nutshell, the measurements show the actual sound coming out of the speaker independent of the room.

That being said, I’d go with the Eris E3.5s if self-noise is important for you. The MR4s have a bit more low-end, but both of these monitors don’t get into sub-bass. The goods description must be the normal trade description expressed in sufficiently precise terms to allow immediate and unambiguous identification and classification. Seems to me it would have been cheaper and more effective to have built new Nimrod MR4s, or similar platform, from scratch rather than upgrading the old airframes. Enter the code for the office of destination in the format ‘2a country+6nOffice identifier’ for example, GB000051.UK – NCTS EDI Traders Message Completion Rules 1. Document Control 1.1 Configuration Management 1.1.2 Change log Version

Enter the office of departure code in the format ‘2a country+6nOffice identifier’ for example, GB000051. As I already stated, it’s pretty obvious that the Edifier MR4 and the PreSonus E3.5 have more similarities than none.This field must only be completed at item level if the code ‘T- was used to code the field ‘Declaration Type’ in the header. These tables provide only a basic guide to the co-relation between the data fields on the IE message and the boxes on the Single Administrative Document ( SAD) document formerly used for the paper based transit declaration and the information required for completing the fields. That being said, I’ve been using small studio monitors for over 2 years now. I reserve my Beyerdynamic DT770 Pros for sub-bass “sculpting”. Press RD, Love Z, Tronnes AA. BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with CML. Blood. 2006; 107(11):4250-4256. PubMed https://doi.org/10.1182/blood-2005-11-4406 Google Scholar Note: the code ‘952’ and related TIR carnet number must only appear once for a declaration and this must be in the first goods item although not necessarily in the first field of box 44.

Patients expressing the BCR-ABL1 e14a2 transcript achieved sMR3 more rapidly at 12.2 months (range: 1-130 months) than those expressing e13a2 at 21.4 months (range: 1-144 months; P=0.019) and were more likely to achieve sMR4, with 5-year probabilities of 81% (range: 74-86.5%) compared to 72.8% (95%CI: 64.8-79.6; P=0.009) for those with the e13a2 transcript ( Online Supplementary Figure S1A and B). Loss of sustained responses Marin D, Milojkovic D, Olavarria E. European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor. Blood. 2008; 112(12):4437-4444. PubMed https://doi.org/10.1182/blood-2008-06-162388 Google Scholar The waveguide pays dividends in directivity and beamwidth in the horizontal axis. It is unusually good for speakers in this price range and even higher: Davis, N.J. (1998). "Nimrod MRA4: Collaborative Crew Performance Challenges" (PDF). rta.nato.int. Archived from the original (PDF) on 22 July 2011 . Retrieved 17 February 2011.

Online Supplementary Table S1 shows a comparison of clinical and CML-related characteristics between patients who achieved sMR3 only and those who reached sMR4. We observed a significant difference in the number of patients treated with high-dose imatinib and in the proportion of those with a history of resistance to first-line TKI ( P=0.02 and P=0.0002, respectively), both more common in the sMR3 only group. This field is to be used only under Normal Procedure, when the goods are situated in a customs location:

It is possible that we have underestimated the probability of loss of MR3 in the patients who achieved only sMR3 because this group may contain two distinct sub-populations: those who are destined to achieve sMR4 with longer follow up (and therefore have a better outcome) and those who do not have the biological potential to achieve deeper responses. We consider this unlikely because the median duration of follow up in patients who achieved sMR3 only was long (56.9 months), whereas the median time to sMR4 was 29.1 months (range: 3.3-172.1 months) from start of TKI therapy, such that sMR4 should have been observed had it been destined to occur. To ask the Secretary of State for Defence, whether the P-8 Poseidon will be capable of carrying UK Storm Shadow and other manufactured munitions.” It just couldn’t be made to fly right. That hadn’t stopped programs in the past, but post Haddon-Cave report (which was due to a Nimrod crash and exposed failures in every aspect of its design, certification and in service managment of airworthiness) – safety was now being taken seriously and so there was no way forward. Note: The movement released state will only be attained when the unloading is complete and the control results are satisfactory or when unsatisfactory have been released by the NCTS office of destination.Fujisawa S, Ueda Y, Usuki K, Kobayashi H, Kondo E, Doki N, Nakao T, Kanda Y, Kosugi N, Kosugi H, Kumagai T, Harada H, Shikami M, Maeda Y, Sakura T, Inokuchi K, Saito A, Nawa Y, Ogasawara M, Nishida J, Kondo T, Yoshida C, Kuroda H, Tabe Y, Maeda Y, Imajo K, Kojima K, Morita S, Komukai S, Kawaguchi A, Sakamoto J, Kimura S. Fujisawa S, et al. Int J Clin Oncol. 2019 Apr;24(4):445-453. doi: 10.1007/s10147-018-1368-2. Epub 2018 Nov 12. Int J Clin Oncol. 2019. PMID: 30421023 Free PMC article. Clinical Trial. Authorised locations must be approved by the designated office of destination and must be specified in the trader’s authorisation. Note: Not to be used with multi-item declarations where more than 1 country of dispatch is declared. Ripley, Time. "RAF 'super-base' plan leaves future of Kinloss in doubt". scotsman.com, 6 September 2004.